Acer Therapeutics Inc. (NASDAQ: ACER) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. It plans to acquire commercial or near-commercial stage drugs into the U.S., the E.U. and other jurisdictions to treat rare or ultra rare diseases. In addition to its existing pipeline (discussed below) it plans to acquire and bring to market at least one new orphan or ultra-orphan drug each year.
For those unfamiliar with